<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Experience from 73 consecutive patients with non-hemolytic, isolated <z:hpo ids='HP_0002904'>hyperbilirubinemia</z:hpo> indicates that such patients almost without exception have increased serum levels of unconjugated <z:chebi fb="0" ids="16990">bilirubin</z:chebi> (greater than 17 mumol/l) and a conjugated <z:chebi fb="0" ids="16990">bilirubin</z:chebi> of less than 30% of total </plain></SENT>
<SENT sid="1" pm="."><plain><z:mpath ids='MPATH_458'>Normal</z:mpath> total <z:chebi fb="0" ids="16990">bilirubin</z:chebi> values were observed in 15% of 500 determinations, although some subjects never had <z:mpath ids='MPATH_458'>normal</z:mpath> values </plain></SENT>
<SENT sid="2" pm="."><plain>The reduced caloric intake test had a low 'sensitivity' as a test for diagnosing <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e>, particularly in females </plain></SENT>
<SENT sid="3" pm="."><plain>Long-term (9-29 years) follow-up study demonstrated that <z:hpo ids='HP_0002904'>hyperbilirubinemia</z:hpo> is lifelong and not associated with increased morbidity or deficiency of coagulation factors II, VII, and X </plain></SENT>
<SENT sid="4" pm="."><plain>The data suggest that no further medical study is necessary in subjects with moderate isolated <z:hpo ids='HP_0002904'>hyperbilirubinemia</z:hpo> and <z:mpath ids='MPATH_458'>normal</z:mpath> blood reticulocyte count </plain></SENT>
</text></document>